We are live on ! Find out more
CPA

Capital Performance Advisors Portfolio holdings

AUM $1.5B
1-Year Est. Return 21.4%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+21.4%
3 Year Est. Return
+61.53%
5 Year Est. Return
10 Year Est. Return
AUM
$329M
AUM Growth
+$65.6M
Cap. Flow
+$47.9M
Cap. Flow %
14.56%
Top 10 Hldgs %
61.59%
Holding
2,901
New
2,799
Increased
53
Reduced
27
Closed
2

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$772K
2
NVDA icon
NVIDIA
NVDA
+$662K
3
AAPL icon
Apple
AAPL
+$589K
4
MSFT icon
Microsoft
MSFT
+$568K
5
AVGO icon
Broadcom
AVGO
+$431K

Sector Composition

Rank Sector Weight
1 Technology 10.08%
2 Financials 4.66%
3 Consumer Discretionary 2.92%
4 Healthcare 2.04%
5 Industrials 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NN icon
2801
NextNav
NN
$1.69B
$45 ﹤0.01%
+6
New +$46
RDHL
2802
Redhill Biopharma
RDHL
$4.14M
$44 ﹤0.01%
+5
New +$49
SUNS
2803
Sunrise Realty Trust
SUNS
$108M
$43 ﹤0.01%
+3
New +$38
ABSI icon
2804
Absci
ABSI
$1.31B
$42 ﹤0.01%
+11
New +$44
FOXF icon
2805
Fox Factory Holding Corp
FOXF
$783M
$42 ﹤0.01%
+1
New +$43
MRDN
2806
Meridian Holdings Inc
MRDN
$177M
$42 ﹤0.01%
+2
New +$57
OBIO icon
2807
Orchestra BioMed
OBIO
$230M
$41 ﹤0.01%
+8
New +$52
EU
2808
enCore Energy
EU
$233M
$40 ﹤0.01%
+10
New +$37
GES
2809
DELISTED
Guess Inc
GES
$40 ﹤0.01%
+2
New +$42
IMTM icon
2810
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.09B
$40 ﹤0.01%
+1
New +$39
TBPH icon
2811
Theravance Biopharma
TBPH
$875M
$40 ﹤0.01%
+5
New +$43
MBI icon
2812
MBIA
MBI
$289M
$39 ﹤0.01%
+11
New +$45
MQ icon
2813
Marqeta
MQ
$1.86B
$39 ﹤0.01%
+2
New +$42
YMAB
2814
DELISTED
Y-mAbs Therapeutics
YMAB
$39 ﹤0.01%
+3
New +$38
KYTX icon
2815
Kyverna Therapeutics
KYTX
$489M
$39 ﹤0.01%
+8
New +$62
ATOS icon
2816
Atossa Therapeutics
ATOS
$23.9M
$38 ﹤0.01%
+2
New +$40
CGON icon
2817
CG Oncology
CGON
$6.36B
$38 ﹤0.01%
+1
New +$35
LIT icon
2818
Global X Lithium & Battery Tech ETF
LIT
$1.49B
$38 ﹤0.01%
+1
New +$38
PBYI icon
2819
Puma Biotechnology
PBYI
$412M
$38 ﹤0.01%
+15
New +$45
ROOT icon
2820
Root
ROOT
$949M
$38 ﹤0.01%
+1
New +$52
USNA icon
2821
Usana Health Sciences
USNA
$410M
$38 ﹤0.01%
+1
New +$41
ENVX icon
2822
Enovix
ENVX
$897M
$37 ﹤0.01%
+5
New +$52
KRO icon
2823
KRONOS Worldwide
KRO
$704M
$37 ﹤0.01%
+3
New +$35
NTIC icon
2824
Northern Technologies International Corp
NTIC
$76.1M
$37 ﹤0.01%
+3
New +$40
ALXO icon
2825
ALX Oncology
ALXO
$277M
$36 ﹤0.01%
+20
New +$74

Similar funds

Capital Performance Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Capital Performance Advisors held 2,901 positions worth $329M, up 25% from $263M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Capital Performance Advisors deployed $47.9M of net new capital in Q3 2024, opening 2,799 new positions and adding to 53 existing holdings. Its largest new stake was Broadcom: 2,686 shares worth $463K.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 8.6% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dimensional US Core Equity 2 ETF, an estimated $521K trimmed.

  • Capital Performance Advisors's largest Q3 2024 buy was Broadcom: 2,686 shares worth $463K.
  • Capital Performance Advisors added most to Amazon in Q3 2024, an estimated $772K increase.
  • Capital Performance Advisors's biggest Q3 2024 reduction was Dimensional US Core Equity 2 ETF, cutting an estimated $521K.
  • Capital Performance Advisors fully exited Dimensional US Core Equity 1 ETF in Q3 2024, selling an estimated $497K.
  • Capital Performance Advisors's ten largest holdings make up 62% of its $329M portfolio in Q3 2024.
  • Capital Performance Advisors opened 2,799 new positions and closed 2 in Q3 2024.
  • Capital Performance Advisors's portfolio value rose 25% quarter-over-quarter to $329M.

Based on Capital Performance Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.